Target Name: CYB5D2
NCBI ID: G124936
Review Report on CYB5D2 Target / Biomarker Content of Review Report on CYB5D2 Target / Biomarker
CYB5D2
Other Name(s): cytochrome b5 domain-containing protein 2 | Neuferricin | Cytochrome b5 domain containing 2, transcript variant 1 | cytochrome b5 domain containing 2 | Cytochrome b5 domain-containing protein 2 | Neuferricin (isoform 1) | CYB5D2 variant 1 | NEUFC_HUMAN

Understanding CYB5D2: A Potential Drug Target and Biomarker

CYB5D2, also known as cytochrome b5 domain-containing protein 2, is a protein that is expressed in various tissues throughout the body. It is a member of the cytochrome P450 (CYP) gene family, which encodes a superfamily of enzymes that are involved in the metabolism of a wide variety of drugs, including drugs that are used for both therapeutic and recreational purposes.

One of the unique features of CYB5D2 is its structure. It is a 63-kDa protein that consists of a single polypeptide chain that is composed of 194 amino acid residues. The protein has a cytoplasmic localization and is predominantly found in the endoplasmic reticulum (ER) and the mitochondria.

CYB5D2 is involved in the metabolism of a wide variety of drugs, including many statins, antidepressants, and opioids. It is a potent inhibitor of CYP3A4, which is an enzyme that is involved in the metabolism of many drugs, including many statins. This means that when CYB5D2 is present in the liver, it can significantly reduce the amount of these drugs that are metabolized and can potentially lead to increased levels of drug toxicity.

CYB5D2 is also known as a potential drug target because of its involvement in the metabolism of drugs. Because it is a potent inhibitor of CYP3A4, it is a potential target for drugs that are used for both therapeutic and recreational purposes. For example, some studies have suggested that CYB5D2 may be a potential drug target for statins, which are used to treat high cholesterol and cardiovascular disease.

In addition to its potential as a drug target, CYB5D2 has also been shown to have a number of potential biological functions. For example, it has been shown to play a role in the regulation of cellular processes that are involved in cell signaling, including the regulation of cell growth and the detoxification of harmful substances.

CYB5D2 has also been shown to have a number of potential applications in diagnostic research. Because it is expressed in various tissues throughout the body, it has been suggested as a potential biomarker for a number of diseases, including cancer, neurodegenerative diseases, and liver disease.

In conclusion, CYB5D2 is a protein that is involved in the regulation of many cellular processes that are important for the health and function of the body. Its structure and function have led to its potential as a drug target, and its involvement in the metabolism of drugs makes it a promising candidate for diagnostic research. Further research is needed to fully understand the role of CYB5D2 in the regulation of cellular processes and its potential applications in medicine.

Protein Name: Cytochrome B5 Domain Containing 2

Functions: Heme-binding protein which promotes neuronal but not astrocyte differentiation

The "CYB5D2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYB5D2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CYB5R1 | CYB5R2 | CYB5R3 | CYB5R4 | CYB5RL | CYBA | CYBB | CYBC1 | CYBRD1 | CYC1 | Cyclin | Cyclin A | Cyclin B | Cyclin D | Cyclin D2-CDK4 complex | Cyclin-dependent kinase | Cyclin-dependent kinase inhibitor | Cyclooxygenase (COX) | Cyclophilins | CYCS | CYCSP25 | CYCSP34 | CYCSP38 | CYCSP51 | CYCSP52 | CYCSP53 | CYCSP55 | CYFIP1 | CYFIP2 | CYGB | CYLC1 | CYLC2 | CYLD | CYLD-AS1 | CYMP | CYP11A1 | CYP11B1 | CYP11B2 | CYP17A1 | CYP19A1 | CYP1A1 | CYP1A2 | CYP1B1 | CYP1B1-AS1 | CYP20A1 | CYP21A1P | CYP21A2 | CYP24A1 | CYP26A1 | CYP26B1 | CYP26C1 | CYP27A1 | CYP27B1 | CYP27C1 | CYP2A13 | CYP2A6 | CYP2A7 | CYP2A7P1 | CYP2B6 | CYP2B7P | CYP2C18 | CYP2C19 | CYP2C61P | CYP2C8 | CYP2C9 | CYP2D6 | CYP2D7 | CYP2D8P | CYP2E1 | CYP2F1 | CYP2F2P | CYP2G1P | CYP2J2 | CYP2R1 | CYP2S1 | CYP2T1P | CYP2U1 | CYP2U1-AS1 | CYP2W1 | CYP39A1 | CYP3A4 | CYP3A43 | CYP3A5 | CYP3A51P | CYP3A7 | CYP3A7-CYP3A51P | CYP3AP2 | CYP46A1 | CYP4A11 | CYP4A22 | CYP4B1 | CYP4F11 | CYP4F12 | CYP4F2 | CYP4F22 | CYP4F26P | CYP4F29P | CYP4F3 | CYP4F30P | CYP4F34P